April 2024 Medicare Drug List Updates: Forty-seven (47) medications added to the 2024 Medicare Part D Drug plan formularies.

The April 2024 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and the drug finder Drug Finder.

The April formulary updates include the addition of 67 new National Drug Codes (NDCs), representing 47 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).

Highlights of the April 2024 Formulary updates include eight (8) newly-introduced brand-name drugs

The April drug data updates include nineteen (19) new brand-name drugs, eight (8) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:

AGAMREE®,
IWILFIN®,
PENBRAYA®,
VOQUEZNA®,
WAINUA®,
XALKORI ®,
ZILBRYSQ®, and
ZITUVIO®.

The April 2024 Formulary updates include ten (10) newly-added generic drugs

The April Medicare Part D drug data also includes twenty-eight (28) new generic medications, ten (10) of which are newly-introduced generic drugs. These new generic drugs include:

BROMFENAC SODIUM [Prolensa®],
CLOBETASOL [Temovate Scalp®],
DAPAGLIFLOZIN [Farxiga®],
DAPAGLIFLOZIN-METFORMIN [Xigduo XR®],
FLUOROMETHOLONE [FML®],
FLURAZEPAM [Dalmane®],
GABAPENTIN [Gralise®],
INSULIN GLARGINE [Toujeo SoloStar®],
RISPERIDONE [Risperdal Consta®], and
RISPERIDONE [Rykindo®].

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.

Reminders about Medicare prescription drug plan formulary changes

Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.
In most cases, your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging. You can read more on this site

Summary of April 2024 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 67 new April 2024 NDCs is as follows:

Reason for NDC Addition	Occurrences
New Delivery Form	3
New Delivery Form and Strength	5
New Drug	17
New Drug and Delivery Form	2
New Drug and Strength	28
New Manufacturer	1
New Manufacturer and Delivery Form	1
New Manufacturer and Strength	7
New Manufacturer, Strength and Delivery Form	1
New Strength	2
Grand Total	67

The following chart details the 67 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state). You can then change the state in our search form for details of drug coverage in your service area.

NDC	Drug Name	Number of PDP Formularies*	Number of MAPD Formularies*	Notes
69616026438	AGAMREE 40 MG/ML ORAL SUSPENSION	0	3	New Drug
00168026415	ALCLOMETASONE DIPR 0.05% OINTMENT [Aclovate]	42	340	New Manufacturer and Delivery Form
53746024830	ALOSETRON HCL 0.5 MG TABLET [Lotronex]	54	369	New Drug and Strength
53746024930	ALOSETRON HCL 1 MG TABLET [Lotronex]	54	369	New Drug and Strength
73308040760	AMCINONIDE 0.1% OINTMENT [Cyclocort]	2	47	New Drug
69489020130	AMZEEQ 4% FOAM	0	1	New Drug
68308075130	BIJUVA 0.5 MG-100 MG CAPSULE	2	22	New Manufacturer and Strength
70539040004	BINOSTO 70 MG EFFERVESCENT TABLET	0	3	New Drug
00069101415	BOSULIF 100 MG CAPSULE	52	365	New Delivery Form and Strength
00069050430	BOSULIF 50 MG CAPSULE	52	366	New Delivery Form and Strength
82260060203	BROMFENAC SODIUM 0.07% EYE DROPS [Prolensa]	25	205	New Drug
45802088996	CALCIPOTRIENE-BETAMETH DP SUSPENSION [Taclonex Scalp]	1	29	New Drug
58151007993	CARDURA XL 8 MG TABLET ER 24H	0	25	New Manufacturer and Strength
73473030660	CLINDA-TRETINOIN 1.2%-0.025% GEL [Ziana]	1	11	New Drug
00168026950	CLOBETASOL 0.05% SOLUTION [Temovate Scalp]	41	362	New Drug
16714049602	CLOTRIMAZOLE-BETAMETHASONE CREAM (G) [Lotrisone]	54	369	New Drug
66993045730	DAPAGLIFLOZIN 10 MG TABLET [Farxiga]	0	7	New Drug and Strength
66993045630	DAPAGLIFLOZIN 5 MG TABLET [Farxiga]	0	7	New Drug and Strength
66993036230	DAPAGLIFLOZIN-METFOR ER 10-1000 TABLET BP 24H [Xigduo XR]	0	6	New Drug and Strength
66993036160	DAPAGLIFLOZIN-METFOR ER 5-1000 TABLET BP 24H [Xigduo XR]	0	6	New Drug and Strength
62135043230	DISULFIRAM 500 MG TABLET [Antabuse]	54	343	New Drug
72578008707	FLUOCINONIDE 0.1% CREAM (G) [Vanos]	6	99	New Drug
60219158503	FLUOROMETHOLONE 0.1% EYE DROPS with DROPPER [FML]	48	368	New Drug
62135073630	FLURAZEPAM 15 MG CAPSULE [Dalmane]	1	28	New Drug and Strength
62135073730	FLURAZEPAM 30 MG CAPSULE [Dalmane]	1	32	New Drug and Strength
45802044102	FLUTICASONE PROP 0.05% LOTION [Cutivate]	3	51	New Delivery Form and Strength
69616029038	FYCOMPA 0.5 MG/ML ORAL SUSPENSION	54	369	New Manufacturer, Strength and Delivery Form
69616028030	FYCOMPA 10 MG TABLET	54	369	New Drug and Strength
69616028230	FYCOMPA 12 MG TABLET	54	369	New Drug and Strength
69616027230	FYCOMPA 2 MG TABLET	54	369	New Drug and Strength
69616027430	FYCOMPA 4 MG TABLET	54	369	New Drug and Strength
69616027630	FYCOMPA 6 MG TABLET	54	369	New Drug and Strength
69616027830	FYCOMPA 8 MG TABLET	54	369	New Drug and Strength
68382060816	GABAPENTIN ER 300 MG TABLET 24H [Gralise]	0	46	New Manufacturer and Strength
68382060716	GABAPENTIN ER 600 MG TABLET 24H [Neurontin]	0	46	New Manufacturer and Strength
70183024130	INPEFA 400 MG TABLET	0	16	New Strength
00955290002	INSULIN GLARGINE MAX SOLO U300 INSULN PEN [Toujeo SoloStar]	0	44	New Drug and Strength
00955390003	INSULIN GLARGINE SOLOSTAR U300 INSULN PEN [Toujeo SoloStar]	0	44	New Drug and Strength
78670015001	IWILFIN 192 MG TABLET	54	367	New Drug
10337090510	Kerydin 5% Solution with Applicator 10 ML	0	2	New Drug
58151015777	LIPITOR 40 MG TABLET	0	4	New Manufacturer and Strength
64380016001	MEGESTROL ACET 40 MG/ML ORAL SUSPENSION [Megace]	54	369	New Delivery Form
13668048750	MINOCYCLINE HCL 100 MG TABLET [Myrac]	12	184	New Strength
45802011942	MOMETASONE FUROATE 0.1% OINTMENT [Elocon]	54	369	New Delivery Form
00168008915	NYSTATIN-TRIAMCINOLONE OINTMENT [Mytrex]	30	265	New Drug and Delivery Form
00168008130	Nystatin and Triamcinolone Acetonide 30G Topical Cream	28	269	New Drug and Delivery Form
00069060001	PENBRAYA Prefilled Syringe	54	365	New Drug
00480155408	RISPERIDONE ER 12.5 MG VIAL [Risperdal Consta]	42	296	New Drug and Strength
00480123208	RISPERIDONE ER 25 MG VIAL [Rykindo]	42	296	New Drug and Strength
00480134208	RISPERIDONE ER 37.5 MG VIAL [Rykindo]	42	296	New Drug and Strength
00480145308	RISPERIDONE ER 50 MG VIAL [Rykindo]	42	296	New Drug and Strength
43386070002	SOD SUL-POTASS SUL-MAG SUL SOLN RECON [Suprep]	54	327	New Drug and Strength
16729037010	TADALAFIL 5 MG TABLET [Cialis]	1	73	New Manufacturer and Strength
70726030401	TEGLUTIK 5 MG/ML ORAL SUSPENSION [TIGLUTIK]	3	33	New Manufacturer
72888016230	TRAMADOL HCL 25 MG TABLET	1	8	New Manufacturer and Strength
81520010030	VOQUEZNA 10 MG TABLET	0	4	New Drug and Strength
81520020030	VOQUEZNA 20 MG TABLET	0	4	New Drug and Strength
00310940001	WAINUA 45 MG/0.8 ML AUTOINJECTOR	0	8	New Drug
00069150060	XALKORI 150 MG PELLET DSP CP	54	369	New Delivery Form and Strength
00069025160	XALKORI 20 MG PELLET DSP CP	54	369	New Delivery Form and Strength
00069050760	XALKORI 50 MG PELLET DSP CP	54	369	New Drug
50474099180	ZILBRYSQ 23 MG/0.574 ML SYRINGE	3	47	New Drug and Strength
50474099280	ZILBRYSQ 32.4 MG/0.81 ML SYRINGE	3	47	New Drug and Strength
70710124203	ZITUVIO 100 MG TABLET	0	2	New Drug and Strength
70710124003	ZITUVIO 25 MG TABLET	0	2	New Drug and Strength
70710124103	ZITUVIO 50 MG TABLET	0	2	New Drug and Strength
80610043060	ZORYVE 0.3% FOAM	0	5	New Delivery Form

If your brand-name drug is no longer covered by your Medicare Part D plan, you can use the 30-day notice period (if notice is provided) to:

Ask your prescriber about trying the generic.
Check for an alternative formulary drug.
Ask your plan to cover a non-formulary drug.
You will need to work with your doctor or prescriber to explain why you are not able to use the generic medication or why no other formulary drug is acceptable. If your formulary exception is denied, you have the right to appeal your plan’s decision.
Consider using a Special Enrollment Period and move to another Medicare plan that provides coverage of all your prescription and health needs.

Learn more in our article: How a mid-year formulary change can affect your Medicare Part D drug coverage.

Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the on this site Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.